EPAM Systems, Inc. EPAM ← Back to all reports

EPAM Systems, Inc.

EPAM · Technology
B ★★★ Hold
Aug 18, 2026 · Score 81 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $98.73
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $85.00 ($80.00–$90.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $131.60
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+33.3%

Type A - EPAM Systems, Inc. (EPAM) 20260818 Stock Analysis

📅 EPAM Key Upcoming Events

🏢 Step 1: EPAM Company Overview & Business Model

Q1-A1. What is EPAM?

Q1-A2. How Does EPAM Make Money?

Q1-A3. EPAM’s Revenue Segments & Core Income Sources

Q1-A4. Who Are EPAM’s Competitors?

Q1-A5. EPAM Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: EPAM’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does EPAM Have a Durable Economic Moat?

Q2-A2. Is EPAM’s Growth Sustainable?

Q2-A3. How Does EPAM Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is EPAM Profitable? Financial Health Analysis

Q3-A2. How Profitable Is EPAM? (Margins & ROIC)

Q3-A3. What Drives EPAM’s Returns? (ROIC Breakdown)

Q3-A4. Are EPAM’s Earnings High Quality?

Q3-A5. Is EPAM’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: EPAM Forensic Accounting & Dilution Review

Q4-A1. Does EPAM Have Accounting Red Flags?

Q4-A2. Is EPAM Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is EPAM’s Cash Flow?

Q4-A4. Is EPAM Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: EPAM Management & Shareholder Alignment

Q5-A1. Can You Trust EPAM’s Management? (Guidance Track Record)

Q5-A2. What Are EPAM Insiders Doing?

Q5-A3. Is EPAM’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: EPAM Market Flow & Sentiment

Q6-A1. Analyst Consensus vs EPAM Guidance

Q6-A2. What Is EPAM’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: EPAM Catalysts & Price Triggers

Q7-A1. What Could Move EPAM Stock? (Top 3 Catalysts)

Q7-A2. EPAM’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is EPAM Fairly Valued? Valuation Analysis

Q8-A1. EPAM’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. EPAM vs Peers: Valuation Comparison

Q8-A3. Is EPAM Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into EPAM? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From EPAM? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. EPAM’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of EPAM? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to EPAM?

Q9-A2. How Sensitive Is EPAM to the Economy?

Q9-A3. EPAM Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: EPAM Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy EPAM? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. EPAM’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is EPAM’s Exposure to Legacy Task-Based Software Engineering Its Biggest Weakness?

Q2: Can EPAM’s 7.6x Forward P/E Be Justified by the AI-Native Transformation Supercycle?

Q3: Will the Leadership Transition to Balazs Fejes Accelerate EPAM’s Strategic Pivot?

Q4: How Does the S&P SmallCap 600 Demotion Impact EPAM’s Institutional Liquidity and Ownership Base?

Q5: Can EPAM Successfully Integrate First Derivative and NEORIS Without Diluting Profitability?

Q6: Is EPAM’s Q2 2026 Negative Operating Cash Flow a Structural Flaw or a Temporary Working Capital Friction?

Q7: How Effectively Can EPAM Capitalize on Its Elite OpenAI and Databricks Partnerships?

Q8: Does the Elevated 15.8% Short Interest in EPAM Signal Unseen Fundamental Deterioration?

Q9: Can EPAM Defend Its Core Engineering Moat Against the Proliferation of Generative AI Coding Assistants?

Q10: Are EPAM’s 16% Margin Expansion Targets Realistic Amid Increased Variable Compensation Pressures?